Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals.
Financial Results:
Ipca Laboratories Ltd reported Revenues for Q4FY24 of ₹2,033.01 Crores up from ₹1,511.63 Crore year on year, a rise of 34.49%.
Total Expenses for Q4FY24 of ₹1,838.61 Crores up from ₹1,418.58 Crores year on year, a rise of 29.61%.
Consolidated Net Profit of ₹1.33 Crores down 98.3% from ₹78.14 Crores in the same quarter of the previous year.
The Earnings per Share is ₹2.35, down 22.19% from ₹3.02 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.